The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

Lesley Jenkins had surgery to remove a tumour that was discovered following a routine bowel test.

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.

In a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a ...